Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.

导出 LinkOut

翻译打印收藏纠错

作者： Mathias,Jachs ^[1] ; Marlene,Panzer ^[2] ; Lukas,Hartl ^[3] ; Michael,Schwarz ^[1] ; Lorenz,Balcar ^[2] ; Jeremy V,Camp ^[1] ; Petra,Munda ^[2] ; Mattias,Mandorfer ^[1] ; Michael,Trauner ^[2] ; Stephan W,Aberle ^[4] ; Heinz,Zoller ^[1] ; Thomas,Reiberger ^[2] ; Peter,Ferenci ^[1]

作者单位： Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. ^[1] Rare Liver Disease (RALID) Center of the European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER), Medical University Vienna, Vienna, Austria. ^[2] Department of Medicine I and Christian Doppler Laboratory on Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria. ^[3] Center for Virology, Medical University of Vienna, Vienna, Austria. ^[4]

关键词 Antivirals Cirrhosis Hepatitis D Treatment Viral hepatitis

DOI 10.1016/j.jhepr.2023.100751

PMID 37360907

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JHEP reports

2023年5卷8期

100751页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.

JHEP reports

相似文献

JHEP reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.

JHEP reports

相似文献

JHEP reports

相关期刊

检索历史清除